文献速递主动脉外科

循环DPP3可预测胸腹主动脉术后死亡与器官衰竭

In-hospital mortality and organ failure after open and endovascular thoraco-abdominal aortic surgery can be predicted by increased levels of circulating dipeptidyl peptidase 3.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

术后17例(51.5%)发生器官衰竭,6例(18.2%)死亡;ICU后12小时DPP3在死亡或器官衰竭患者中显著升高,对住院死亡和器官衰竭具有较高预测准确性。

要点

  • TAAA修复术后器官衰竭发生率为51.5%,住院死亡率为18.2%。
  • ICU后12小时cDPP3升高与死亡或器官衰竭显著相关。
  • cDPP3对住院死亡和器官衰竭的AUC在12至48小时达0.815至0.914。

核心结论

  • cDPP3可作为TAAA修复术后早期预测住院死亡和器官衰竭的高特异性生物标志物。

研究设计与样本

  • 围术期连续监测cDPP3至ICU后72小时,终点为住院死亡和任何器官衰竭。

主要发现

  • 术后17例(51.5%)发生器官衰竭,6例(18.2%)死亡。
  • ICU后12小时cDPP3在死亡或器官衰竭患者中显著升高(P < 0.001)。
  • cDPP3预测住院死亡:12小时AUC 0.907(P < 0.001),24小时AUC 0.815(P = 0.016),48小时AUC 0.914(P = 0.003)。
  • cDPP3预测器官衰竭:12小时AUC 0.882(P < 0.001),24小时AUC 0.850(P < 0.001),48小时AUC 0.846(P < 0.001)。
  • cDPP3与SOFA评分、降钙素原、C反应蛋白和白细胞介素-6显著相关(P < 0.001、P < 0.001、P = 0.011、P = 0.007)。

临床怎么用

  • TAAA修复术后可连续监测cDPP3,辅助早期识别高死亡和器官衰竭风险患者。

局限性

  • 单中心小样本观察性研究,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Endovascular and open thoraco-abdominal aortic aneurysm (TAAA) repair is associated with specific complications. Circulating dipeptidyl peptidase 3 (cDPP3) is a novel biomarker that shows a strong association with organ failure which has not been assessed in surgical settings. Therefore, the objective of this study was to assess the prognostic capabilities of cDPP3 for predicting patient survival and organ failure following open and endovascular TAAA repair. METHODS: Thirty-three patients undergoing TAAA repair were assessed in this prospective observational single-centre study. cDPP3 levels were serially measured perioperatively until 72 h after admission to the intensive care unit (ICU). In-hospital mortality and any organ failure were the clinical end points. RESULTS: Postoperative organ failure was detected in 17 patients (51.5%), and 6 patients died after surgery (18.2%). At 12 h after admission to the ICU, cDPP3 levels were significantly increased in patients who died or developed organ failure (P < 0.001). cDPP3 levels after surgery demonstrated a remarkable predictive accuracy for in-hospital mortality [12 h area under the receiver operating characteristic curve (AUC): 0.907 (P < 0.001), 24 h AUC: 0.815 (P = 0.016), 48 h AUC: 0.914 (P = 0.003)] and the development of organ failure [12 h AUC: 0.882 (P < 0.001), 24 h AUC: 0.850 (P < 0.001), 48 h AUC: 0.846 (P < 0.001)]. Additionally, a significant correlation between cDPP3, the sequential organ failure assessment score and procalcitonin, C-reactive protein and interleukin-6 levels (P < 0.001, P < 0.001, P = 0.011, P = 0.007, respectively) based on all available measurements and time points was observed. CONCLUSIONS: The present findings highlight the role of cDPP3 as an early, highly specific postoperative biomarker for prediction of in-hospital mortality and organ failure after TAAA repair.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gombert A, Barbati M, Kotelis D, et al. In-hospital mortality and organ failure after open and endovascular thoraco-abdominal aortic surgery can be predicted by increased levels of circulating dipeptidyl peptidase 3. Eur J Cardiothorac Surg. 2021. PMID: 33236058. doi:10.1093/ejcts/ezaa413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。